VanEck Pharmaceutical ETF
PPH
#1357
ETF rank
โ‚ฌ0.78 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
92,20ย โ‚ฌ
Share price
1.68%
Change (1 day)
20.75%
Change (1 year)

Expense ratio and fees for VanEck Pharmaceutical ETF (PPH)

Expense Ratio

Expense Ratio as of May 2025: 0.36%

Gross Expense Ratio

Gross Expense Ratio as of June 2026: 0.36%

Net Expense Ratio

Net Expense Ratio as of June 2026: 0.36%